PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 11, 2026Natural Product Research0 citations

A new eudesmane type sesquiterpenoid from the stem bark of Aglaia pachyphylla with cytotoxic and anti-inflammatory activities

View Full Paper
WSWahyu SafriansyahJSJosephine Elizabeth SiregarEHErina Hilmayanti

Key Points

  • The central aim is to isolate a new eudesmane-type sesquiterpenoid and evaluate its activities against cancer and inflammation.
  • Isolated compounds from n-hexane extract of Aglaia pachyphylla stem bark.
  • Identified the structure of phyllunone A using NMR, HRMS, and computational methods.
  • Assessed cytotoxicity in MCF-7 breast cancer cells and anti-inflammatory activity in RAW 264.7 cells.
  • Phyllunone A was identified as a new eudesmane-type sesquiterpenoid.
  • Compounds 2-3 showed weak cytotoxicity with IC50 values of 343 and 206 µM, respectively.
  • Phyllunone A inhibited TNF-α production by 49.3%, indicating strong anti-inflammatory potential.

Abstract

This study aims to isolate an undescribed eudesmane-type sesquiterpenoid, phyllunone A (1), along with 5 known sesquiterpenoids from n-hexane extract of Aglaia pachyphylla stem bark. The structural elucidation of compound 1 was achieved using NMR, HRMS, ECD, and was further supported by computational calculation (TD-DFT and NMR DP4+). Phyllunone A (1) represented a new eudesmane skeleton bearing a 2,4(11)-dien-1-one moiety. In addition, compounds 1 to 6 were evaluated against MCF-7 breast cancer cells and anti-inflammatory activity (TNF-α production) in RAW 264.7 cells induced by LPS. The results revealed that only compounds 2-3 exhibited weak cytotoxicity (IC50 343 and 206 µM), while the others were inactive. In anti-inflammatory assay, compound 1 showed the highest inhibition of TNF-α production (49.3%), indicating its potential as a non-cytotoxic anti-inflammatory agent.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Safriansyah et al. (2026) studied this question.

synapsesocial.com/papers/698c1bef267fb587c655dfcfhttps://doi.org/10.1080/14786419.2026.2624070
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Discovery of sesquiterpenoids from Chloranthus henryi Hemsl. var. hupehensis (Pamp.)K. F. Wu and their anti-inflammatory activity by suppression of the IKBα/NF-κB p65 signaling pathway2024
  2. 2Sesquiterpenoids from The Stem Bark of Aglaia cucullata (Meliaceae) and Their Cytotoxic Activity Against A549 Lung Cancer Cell Lines2024
  3. 3Studies on secondary metabolites and anti-inflammatory activity of fungus <i>Penicillium citreosulfuratum</i> YFC-1 from <i>Sphagneticola trilobata</i>2026
  4. 4Penta- and Tetra-cyclic Triterpenoids from Aglaia cucullata Stembark and Cytotoxicity against Cancer and Normal Cells2025
  5. 5A novel tetranortirucallane-type alkaloid with potential anti-inflammatory activity from <i>Aglaia lawii</i>2025